National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: The medicare health care quality improvement program

Archives of Internal Medicine

Volumn 163, Issue 12, 2003, Pages 1430-1439

  Burwen, Dale R ^a   Galusha, Deron H ^b   Lewis, Jennifer M ^b   Bedinger, Marjorie R ^a   Radford, Martha J ^b,c   Krumholz, Harlan M ^b,c   Foody, JoAnne Micale ^b,c  

^a Center for Medicare and Medicaid Services   (United States)

^b QUALIDIGM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG UTILIZATION; EVALUATION; EVIDENCE BASED MEDICINE; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SERVICE; HEART MUSCLE REPERFUSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL RECORD; MEDICARE; OUTCOMES RESEARCH; PATIENT COUNSELING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SMOKING CESSATION; TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MEDICARE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; SMOKING CESSATION; THROMBOLYTIC THERAPY; TIME FACTORS; UNITED STATES;

EID: 0037903063     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.12.1430     Document Type: Article

References (27)

1. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-121.
2. Barron HV, Rundle A, Gurwitz J, Tiefenbrunn A. Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2. Cardiol Rev. 1999;7:156-160.
3. O'Connor GT, Quinton HB, Traven ND, et al. Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA. 1999;281:627-633.
4. Jencks SJ, Cuerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: a profile at state and national levels. JAMA. 2000;284:1670-1676.
5. Quality First: Better Health Care for All Americans. Washington, DC: President's Advisory Commission on Consumer Protection and Quality in the Health Care Industry; 1998.
6. Committee on Quality of Health Care in American, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
7. National Committee for Quality Assurance. NCQA's State of Managed Care Quality Report. Washington, DC: Government Printing Office; 2000.
8. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000;36:2056-2063.
9. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA. 1998;279:1351-1357.
10. McGovern PG, Pankow JS, Shahar E, et al, for the Minnesota Heart Survey Investigators. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med. 1996;334:884-890.
11. Dauerman HL, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Ten-year trends in the incidence, treatment, and outcome of Q-wave myocardial infarction. Am J Cardiol. 2000;86:730-735.
12. Goldberg RJ, Yarzebski J, Lessard D, Gore JM. A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol. 1999;33:1533-1539.
13. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998; 280:623-629.
14. Huff ED. Comprehensive reliability assessment and comparison of quality indicators and their components. J Clin Epidemiol. 1997;50:1395-1404.
15. NHS Centre for Reviews and Dissemination. Effective Health Care: Getting Evidence Into Practice. London, England: Royal Society of Medicine Press Ltd; 1999:1-16.
16. Doorey A, Patel S, Reese C, et al. Dangers of delay of initiation of either thrombolysis or primary angioplasty in acute myocardial infarction with increasing use of primary angioplasty. Am J Cardiol 1998;81:1173-1177.
17. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients wtih acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996;28:1328-1428.
18. Hand M, Brown C, Horan M, Simons-Morton D. The National Heart Attack Alert Program: progress at 5 years in educating providers, patients, and the public and future directions. J Thromb Thrombolysis. 1998;6:9-17.
19. National Committee for Quality Assurance. HEDIS 3.0, Technical Specifications. Vol 2. Washington, DC: Government Printing Office; 1997.
20. American Medical Association. Quality Care Alert: Beta-Blocker Prophylaxis After Acute Myocardial Infarction. October 1998. Available at: www.ama-assn.org /meetings/public/int1998/news/qca.htm. Accessed February 12, 2003.
21. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981; 304:801-807.
22. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet. 1981;2:823-827.
23. Beta-blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA. 1982; 247:1707-1714.
24. Ryan TJ, Antman EM, Brooks NH, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: 1999 update: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Available at: http: //www.acc.org/clinical/guidelines/nov96/1999/index.htm. Accessed March 3, 2003.
25. Krumholz HM, Radford MJ, Wang Y, Chen J, Marciniak TA. Early β-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med. 1999;131:648-654.
26. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Do "America's Best Hospitals" perform better for acute myocardial infarction? N Engl J Med. 1999; 340:286-292.
27. Health Care Financing Administration. Health Care Quality Improvement Program: Medicare priorities. Baltimore, Md: US Dept of Health and Human Services; March 2000. Publication 10156.